ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,714.80
0.18%
다우존스 지수
39,512.84
0.32%
Bitcoin
62,795.43
2.19%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Antares Pharma Inc (ATRS)

  7. Antares Pharma Inc (ATRS) 뉴스

ATRS

Antares Pharma (ATRS)

Antares Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ATRS
일자시간출처헤드라인심볼기업
2022/05/2706:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2706:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:46Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ATRSAntares Pharma Inc
2022/05/2505:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
2022/05/2422:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ATRSAntares Pharma Inc
2022/05/2419:11Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ATRSAntares Pharma Inc
2022/05/1405:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
2022/05/1221:00PR Newswire (US)Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares PharmaNASDAQ:ATRSAntares Pharma Inc
2022/05/1220:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
2022/05/1220:02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ATRSAntares Pharma Inc
2022/05/1106:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
2022/05/1105:42Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ATRSAntares Pharma Inc
2022/05/0701:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ATRSAntares Pharma Inc
 검색 관련기사 보기:NASDAQ:ATRS

최근 히스토리

CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDEUR
US Dollar vs Euro
NASDAQ
AAPL
Apple
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
CCOM
US30
US 30
COIN
ETHUSD
Ethereum
NASDAQ
NVDA
NVIDIA
NYSE
AXP
American Express
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유